OKUR OnKure Therapeutics, Inc. - Class A Common Stock
OKUR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
OKUR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
OKUR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 4 33,3%
- Kauf 6 50,0%
- Halten 2 16,7%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
4 Analysten · 2026-08-18Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.31 | $-0.55 | 0.24% |
| 31. März 2026 | $-1.11 | $-0.76 | -0.35% |
| 31. Dezember 2025 | $-0.99 | $-1.18 | 0.18% |
| 30. September 2025 | $-1.09 | $-1.22 | 0.13% |
| 30. Juni 2025 | $-1.14 | $-1.27 | 0.13% |
| 31. März 2025 | $-1.19 | $-1.49 | 0.30% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| OKUR | — | -0.7 | — | -1733.7% | -88.6% | — |
| CNTN | $112M | -2.7 | — | — | -18.0% | — |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | — |
| INDP | $6M | -0.1 | — | — | -2820.8% | — |
| OTLK | $57M | -0.6 | — | -4416.2% | 193.1% | 4.0% |
| TNYA | $154M | -1.2 | — | — | -81.2% | — |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | — |
| EQ | $95M | -4.0 | 13.9% | — | -133.1% | — |
| SPRB | $120M | -1.7 | -51.3% | — | -139.9% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | · | $0 | |
| R&D Expense | $48M | $44M | |
| SG&A Expense | $15M | $11M | |
| Operating Expenses | $63M | $54M | |
| Operating Income | $-63M | $-54M | |
| Interest Income | $3M | $2M | |
| Income Tax | $0 | $0 | |
| Net Income | $-60M | $-53M | |
| EPS (Basic) | $-4.40 | $-15.28 | |
| EPS (Diluted) | $-4.40 | $-15.28 | |
| Shares (Basic) | 13,515,915 | 3,447,071 | |
| Shares (Diluted) | 13,515,915 | 3,447,071 | |
| EBITDA | $-63M | $-54M |
Bilanz 19
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $59M | $111M | |
| Prepaid Expense | $2M | $2M | |
| Current Assets | $61M | $113M | |
| PP&E (Net) | $618.0K | $1M | |
| PP&E (Gross) | $2M | $2M | |
| Accum. Depreciation | $1M | $1M | |
| Other Non-current Assets | $273.0K | $109.0K | |
| Total Assets | $62M | $115M | |
| Accounts Payable | $1M | $3M | |
| Accrued Liabilities | · | $7M | |
| Current Liabilities | $6M | $11M | |
| Capital Leases | $0 | $549.0K | |
| Other Non-current Liabilities | $12.0K | · | |
| Total Liabilities | $6M | $11M | |
| Paid-in Capital | $270M | $259M | |
| Retained Earnings | $-214M | $-155M | |
| AOCI | $0 | · | |
| Stockholders' Equity | $56M | $104M | |
| Liabilities + Equity | $62M | $115M |
Cashflow 9
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $447.0K | $459.0K | |
| Stock-based Comp | $12M | $5M | |
| Other Non-cash | $-4M | $-3M | |
| Operating Cash Flow | $-52M | $-51M | |
| CapEx | $46.0K | $52.0K | |
| Investing Cash Flow | $-46.0K | $16M | |
| Financing Cash Flow | $163.0K | $116M | |
| Net Change in Cash | $-52M | $81M | |
| Free Cash Flow | $-52M | $-51M |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -1833.7% | · | |
| Net Margin | -1733.7% | · | |
| EBITDA Margin | -1820.6% | · | |
| ROA | -67.2% | -69.9% | |
| ROE | -88.6% | 337.4% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 10.3 | 10.7 | |
| Quick Ratio | 10.0 | 10.5 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 |
Bewertung (TTM) 4
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | · | $0 | |
| Net Income TTM | $-60M | $-53M | |
| P/E | -0.7 | -0.6 | |
| Earnings Yield | -151.7% | -177.7% |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $12M | $11M | $12M | $13M | $13M | $14M | $10M | $11M | $9M | $-7M | $14M | $14M | $11M | $10M | $10M | |
| SG&A Expense | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $1M | $4M | $1M | $-14M | $7M | $7M | $5M | $4M | $4M | |
| Operating Expenses | $17M | $16M | $14M | $16M | $16M | $17M | $19M | $12M | $14M | $10M | $-21M | $21M | $21M | $16M | $15M | $14M | |
| Operating Income | $-17M | $-16M | $-14M | $-16M | $-16M | $-17M | $-19M | $-12M | $-14M | $-10M | $21M | $-21M | $-21M | $-16M | $-15M | $-14M | |
| Interest Income | $2M | $458.0K | $628.0K | $804.0K | $934.0K | $1M | $1M | $174.0K | $230.0K | $295.0K | · | · | · | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | $972.0K | $1M | $1M | · | $2M | $2M | $1M | $962.0K | $833.0K | |
| Net Income | $-15M | $-15M | $-14M | $-15M | $-15M | $-16M | $-17M | $-12M | $-14M | $-10M | $19M | $-19M | $-20M | $-15M | $-14M | $-13M | |
| EPS (Basic) | $-0.31 | $-1.11 | $-0.98 | $-1.09 | $-1.14 | $-1.19 | $96.46 | $-36.55 | $-44.82 | $-30.37 | $-117.48 | $-5.68 | $-0.65 | $-0.60 | $-0.56 | $-0.53 | |
| EPS (Diluted) | $-0.31 | $-1.11 | $-0.98 | $-1.09 | $-1.14 | $-1.19 | $96.46 | $-36.55 | $-44.82 | $-30.37 | $-117.48 | $-5.68 | $-0.65 | $-0.60 | $-0.56 | $-0.53 | |
| Shares (Basic) | 49,869,177 | 13,674,577 | -26,948,392 | 13,530,892 | 13,509,080 | 13,424,335 | 2,501,435 | 316,142 | 315,478 | 314,016 | -58,348,708 | 3,380,794 | 30,215,321 | 25,036,410 | -48,922,002 | 24,496,313 | |
| Shares (Diluted) | 49,869,177 | 13,674,577 | -26,948,392 | 13,530,892 | 13,509,080 | 13,424,335 | 2,501,435 | 316,142 | 315,478 | 314,016 | -58,348,708 | 3,380,794 | 30,215,321 | 25,036,410 | -48,922,002 | 24,496,313 | |
| EBITDA | $-17M | $-16M | · | $-15M | $-16M | $-17M | · | $-5M | $-6M | $-10M | · | $-21M | $-21M | $-16M | · | $-14M |
Bilanz 22
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $192M | $59M | $70M | $83M | $97M | $111M | $61M | $36M | $20M | $30M | $12M | $9M | $30M | $20M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | $16M | $41M | $62M | · | $114M | $134M | $63M | $81M | $54M | |
| Prepaid Expense | $1M | $5M | $2M | $1M | $1M | $2M | $2M | $331.0K | $1M | $1M | $4M | $3M | $4M | $3M | $5M | $5M | |
| Current Assets | $178M | $197M | $61M | $72M | $85M | $98M | $113M | $77M | $78M | $84M | $34M | $129M | $146M | $97M | $106M | $121M | |
| PP&E (Net) | $435.0K | $519.0K | $618.0K | $720.0K | $821.0K | $925.0K | $1M | $59.0K | $81.0K | $102.0K | $1M | $529.0K | $554.0K | $581.0K | $453.0K | $241.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | $2M | · | · | · | $555.0K | · | |
| Accum. Depreciation | $2M | $2M | $1M | $1M | $1M | $1M | $1M | · | · | · | $665.0K | · | · | · | $102.0K | · | |
| Other Non-current Assets | $401.0K | $405.0K | $273.0K | $104.0K | $116.0K | $109.0K | $109.0K | $147.0K | $153.0K | $64.0K | $58.0K | $81.0K | $79.0K | $81.0K | $84.0K | $79.0K | |
| Total Assets | $179M | $199M | $62M | $73M | $86M | $100M | $115M | $78M | $79M | $85M | $36M | $130M | $148M | $99M | $108M | $123M | |
| Accounts Payable | $2M | $11M | $1M | $1M | $2M | $2M | $3M | $237.0K | $64.0K | $676.0K | $3M | $2M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | $5M | $6M | · | $725.0K | $953.0K | $2M | $4M | $11M | $12M | $8M | $5M | $7M | |
| Current Liabilities | $7M | $14M | $6M | $6M | $8M | $9M | $11M | $3M | $1M | $3M | $7M | $14M | $14M | $10M | $7M | $9M | |
| Capital Leases | $590.0K | $0 | · | $120.0K | $267.0K | $409.0K | $549.0K | $379.0K | $492.0K | $576.0K | $466.0K | $812.0K | $897.0K | $979.0K | $1M | $943.0K | |
| Other Non-current Liabilities | $12.0K | $12.0K | $12.0K | $40.0K | $40.0K | $40.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $7M | $14M | $6M | $6M | $8M | $9M | $11M | $4M | $2M | $3M | $8M | $15M | $16M | $12M | $8M | $10M | |
| Common Stock | · | · | · | · | · | · | · | $0 | $3.0K | $3.0K | · | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $417M | $414M | $270M | $267M | $264M | $261M | $259M | $310M | $309M | $308M | $209.0K | $305M | $304M | $239M | $237M | $235M | |
| Retained Earnings | $-245M | $-229M | $-214M | $-201M | $-186M | $-171M | $-155M | $-236M | $-232M | $-227M | $-102M | $-191M | $-171M | $-152M | $-137M | $-123M | |
| AOCI | $-13.0K | · | · | · | · | · | · | $2.0K | $-13.0K | $-12.0K | · | $-21.0K | $-31.0K | $12.0K | $-43.0K | $-26.0K | |
| Stockholders' Equity | $172M | $184M | $56M | $66M | $78M | $91M | $104M | $74M | $77M | $81M | $-102M | $115M | $133M | $87M | $100M | $112M | |
| Liabilities + Equity | $179M | $199M | $62M | $73M | $86M | $100M | $115M | $78M | $79M | $85M | $36M | $130M | $148M | $99M | $108M | $123M | |
| Shares Outstanding | · | · | · | · | · | · | · | 3,343,525 | 33,420,808 | 33,420,808 | · | 33,872,166 | 33,800,788 | 25,107,430 | 24,699,553 | 24,529,646 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $87.0K | $104.0K | $104.0K | $108.0K | $117.0K | $118.0K | $116.0K | $114.0K | $115.0K | $114.0K | $291.0K | $43.0K | $42.0K | $41.0K | $25.0K | $22.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $-70.0K | $842.0K | $107.0K | $-4M | $1M | $1M | $1M | $1M | $990.0K | |
| Other Non-cash | · | $-665.0K | · | · | · | $-943.0K | · | · | · | $-14M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $-10M | $-13M | $-12M | $-13M | $-13M | $-14M | $-23M | $58.0K | $4M | $-11M | $9M | $-19M | $-16M | $-9M | $-16M | $-11M | |
| CapEx | $3.0K | $5.0K | $9.0K | $6.0K | $13.0K | $18.0K | $15.0K | $35.0K | $10.0K | $9.0K | $50.0K | $19.0K | $5.0K | $172.0K | $250.0K | $28.0K | |
| Investing Cash Flow | $-10M | $-5.0K | $-9.0K | $-6.0K | $-13.0K | $-18.0K | $16M | $-36M | $-14M | $-9.0K | $29M | $21M | $-69M | $19M | $-27M | $-45M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-5M | $146M | $240.0K | $0 | $0 | $-77.0K | $110M | $6M | $6M | $10.0K | $-12M | $173.0K | $64M | $1M | $325.0K | $97.0K | |
| Net Change in Cash | $-26M | $133M | $-11M | $-13M | $-13M | $-14M | $103M | $-30M | $-4M | $-11M | $27M | $3M | $-21M | $10M | $-42M | $-56M | |
| Free Cash Flow | · | $-13M | · | · | · | $-14M | · | · | · | · | · | · | · | $-9M | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1088.2% | -3409.4% | · | -1932.8% | -1747.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -988.2% | -3309.4% | · | -1832.8% | -1647.8% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1088.2% | -3386.7% | · | -1919.3% | -1735.2% | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -11.6% | -10.2% | · | -19.5% | -18.7% | -17.3% | · | -3.5% | -4.7% | -9.2% | · | -15.2% | -13.9% | -12.4% | · | -9.1% | |
| ROE | -12.3% | -11.0% | · | -20.9% | -19.9% | -18.5% | · | -3.9% | -5.1% | -10.0% | · | -16.9% | -15.2% | -13.6% | · | -9.7% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.7 | 13.8 | · | 11.4 | 11.1 | 11.2 | · | 23.7 | 57.9 | 29.8 | · | 9.5 | 10.7 | 9.3 | · | 12.8 | |
| Quick Ratio | 25.1 | 13.4 | · | 11.3 | 11.0 | 11.0 | · | 23.6 | 56.9 | 29.4 | · | 9.3 | 10.4 | 8.9 | · | 12.3 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-59M | $-59M | · | $-63M | $-60M | $-59M | · | $-54M | $-62M | $-63M | · | $-67M | $-60M | $-53M | · | $-51M | |
| Market Cap | · | · | · | · | · | · | · | $57M | $505M | $555M | · | $2.58B | $2.22B | $1.50B | · | $822M | |
| P/E | -1.2 | -0.9 | · | -0.1 | -0.0 | -0.0 | · | -0.1 | -0.2 | -0.4 | · | -10.2 | -28.8 | -27.7 | · | -16.1 | |
| P/B | · | · | · | · | · | · | · | 0.8 | 6.6 | 6.8 | · | 22.4 | 16.7 | 17.2 | · | 7.3 | |
| P / Tangible Book | · | · | · | · | · | · | · | 0.8 | 6.6 | 6.8 | · | 22.4 | 16.7 | 17.2 | · | 7.3 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | -26.4 | · | · | · | -165.9 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -162.8 | · | · | |
| Earnings Yield | -80.0% | -109.4% | · | -1453.5% | -3502.1% | -2626.3% | · | -690.7% | -539.9% | -224.7% | · | -9.8% | -3.5% | -3.6% | · | -6.2% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | — | $0 | — | — | — |
| Betriebsgewinnmarge % | -1833.7% | — | — | — | — |
| Nettoergebnis | $-60M | $-53M | $-35M | $-52M | $-40M |
| Verwässerte EPS | $-4.40 | $-15.28 | $-124.41 | $-2.12 | $-2.19 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 10.3 | 10.7 | — | 14.9 | 24.8 |
| Quick Ratio | 10.0 | 10.5 | — | 14.2 | 23.8 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-52M | $-51M | — | $-48M | $-38M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 78 Einreicher · $148.9M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 32 (+14 vs. Vorquartal) | 8 (+1 vs. Vorquartal) | 16 (+3 vs. Vorquartal) | 13 (+1 vs. Vorquartal) | +2.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $18.232.398 | 3.998.333 | 12,25% | Aktien |
| BVF INC/IL | $14.755.148 | 3.235.778 | 9,91% | Aktien |
| ACORN CAPITAL ADVISORS, LLC | $12.948.913 | 2.839.674 | 8,70% | Aktien |
| StepStone Group LP | $11.014.934 | 2.660.612 | 7,40% | Aktien |
| ADAR1 Capital Management, LLC | $10.208.399 | 2.238.684 | 6,86% | Aktien |
| Vivo Capital, LLC | $8.790.358 | 1.927.710 | 5,91% | Aktien |
| Vestal Point Capital, LP | $8.325.187 | 1.825.699 | 5,59% | Aktien |
| Trails Edge Capital Partners, LP | $6.559.359 | 1.438.456 | 4,41% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.552.898 | 1.437.039 | 4,40% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $5.493.975 | 1.204.819 | 3,69% | Aktien |
| CITADEL ADVISORS LLC | $5.412.934 | 1.187.047 | 3,64% | Aktien |
| Sio Capital Management, LLC | $4.920.080 | 1.078.965 | 3,31% | Aktien |
| Prosight Management, LP | $4.464.204 | 978.992 | 3,00% | Aktien |
| Logos Global Management LP | $4.395.179 | 963.855 | 2,95% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $2.788.902 | 611.596 | 1,87% | Aktien |
| NEA Management Company, LLC | $2.182.179 | 478.548 | 1,47% | Aktien |
| STATE STREET CORP | $2.114.299 | 463.662 | 1,42% | Aktien |
| Ensign Peak Advisors, Inc | $1.968.237 | 431.631 | 1,32% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.635.845 | 358.738 | 1,10% | Aktien |
| Sofinnova Investments, Inc. | $1.466.916 | 321.692 | 0,99% | Aktien |
| Carlyle Group Inc. | $1.230.721 | 269.895 | 0,83% | Aktien |
| Seven Fleet Capital Management LP | $1.098.791 | 240.963 | 0,74% | Aktien |
| Affinity Asset Advisors, LLC | $1.098.791 | 240.963 | 0,74% | Aktien |
| DV EQUITIES, LLC | $1.098.791 | 240.963 | 0,74% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $810.613 | 177.766 | 0,54% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $753.207 | 165.177 | 0,51% | Aktien |
| Rosalind Advisors, Inc. | $684.000 | 150.000 | 0,46% | Aktien |
| Stonepine Capital Management, LLC | $595.919 | 130.684 | 0,40% | Aktien |
| KOTLER KEVIN | $573.304 | 197.691 | 0,39% | Aktien |
| Longaeva Partners L.P. | $549.398 | 120.482 | 0,37% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $496.447 | 108.870 | 0,33% | Aktien |
| BANK OF AMERICA CORP /DE/ | $484.819 | 106.320 | 0,33% | Aktien |
| CANTOR FITZGERALD, L. P. | $456.064 | 100.014 | 0,31% | Aktien |
| UBS Group AG | $454.194 | 99.604 | 0,31% | Aktien |
| Rangeley Capital, LLC | $433.200 | 95.000 | 0,29% | Aktien |
| Aisling Capital Management LP | $404.048 | 88.607 | 0,27% | Aktien |
| Walleye Capital LLC | $324.230 | 71.103 | 0,22% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $290.198 | 63.640 | 0,19% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $229.336 | 50.293 | 0,15% | Aktien |
| Shay Capital LLC | $228.000 | 50.000 | 0,15% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $221.766 | 48.633 | 0,15% | Aktien |
| PRELUDE CAPITAL MANAGEMENT, LLC | $212.916 | 46.692 | 0,14% | Aktien |
| Aldebaran Capital, LLC | $181.803 | 39.869 | 0,12% | Aktien |
| Nuveen, LLC | $161.433 | 35.402 | 0,11% | Aktien |
| Verdad Advisers, LP | $130.690 | 28.660 | 0,09% | Aktien |
| Bank of New York Mellon Corp | $119.705 | 26.251 | 0,08% | Aktien |
| DEUTSCHE BANK AG\ | $116.572 | 25.564 | 0,08% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $105.231 | 23.077 | 0,07% | Aktien |
| WELLS FARGO & COMPANY/MN | $100.097 | 21.951 | 0,07% | Aktien |
| RHUMBLINE ADVISERS | $95.736 | 20.996 | 0,06% | Aktien |
| Jump Financial, LLC | $93.024 | 20.400 | 0,06% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $90.694 | 19.889 | 0,06% | Aktien |
| MARSHALL WACE, LLP | $83.744 | 18.365 | 0,06% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $82.536 | 18.100 | 0,06% | Aktien |
| XTX Topco Ltd | $77.383 | 16.970 | 0,05% | Aktien |
| TWO SIGMA ADVISERS, LP | $77.163 | 26.608 | 0,05% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $55.035 | 12.069 | 0,04% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $51.473 | 11.288 | 0,03% | Aktien |
| CITIGROUP INC | $48.687 | 10.677 | 0,03% | Aktien |
| Invesco Ltd. | $47.657 | 10.451 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $47.073 | 10.323 | 0,03% | Aktien |
| MORGAN STANLEY | $29.900 | 6.557 | 0,02% | Aktien |
| BARCLAYS PLC | $20.520 | 4.500 | 0,01% | Aktien |
| NORTHERN TRUST CORP | $18.778 | 4.118 | 0,01% | Aktien |
| Legal & General Group Plc | $11.651 | 2.555 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $10.848 | 2.379 | 0,01% | Aktien |
| Russell Investments Group, Ltd. | $9.557 | 2.096 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $7.346 | 1.611 | 0,00% | Aktien |
| BlackRock, Inc. | $6.644 | 1.457 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $4.000 | 966 | 0,00% | Aktien |
| Sterling Capital Management LLC | $2.408 | 528 | 0,00% | Aktien |
| VANGUARD GROUP INC | $2.161 | 745 | 0,00% | Aktien |
| TRUST CO OF TOLEDO NA /OH/ | $620 | 136 | 0,00% | Aktien |
| OSAIC HOLDINGS, INC. | $410 | 90 | 0,00% | Aktien |
| FMR LLC | $406 | 89 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $203 | 45 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $98 | 21.481 | 0,00% | Aktien |
| T. Rowe Price Investment Management, Inc. | $70 | 15.335 | 0,00% | Aktien |
Unternehmensinsider 28 Insider · 6 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Gregory J. Flesher | President and CEO | 9. Dezember 2022 A | 109.600 | 0 | 0 | $0 |
| Michael Cruse | Chief Operating Officer | 9. Dezember 2022 A | 13.697 | 0 | 0 | $0 |
| Ashley Hall | Chief Development Officer | 28. August 2023 M | 39.600 | 0 | 0 | $0 |
| Jennifer Lam | VP of Finance & Administration | 9. Dezember 2022 A | — | 0 | 0 | $0 |
| Alejandro Dorenbaum | Chief Medical Officer | 9. Dezember 2022 A | 30.000 | 0 | 0 | $0 |
| Wendy S. Johnson | Chief Development Officer | 14. Juli 2021 S | 0 | 0 | 0 | $0 |
| Roshawn A. Blunt | Direktor | 6. Juni 2023 A | — | 0 | 0 | $0 |
| Bali Muralidhar | Direktor | 6. Juni 2023 A | 2.073.957 | 0 | 0 | $0 |
| Niall O'Donnell, Ph.D. | Direktor | 6. Juni 2023 A | 2.188.713 | 0 | 0 | $0 |
| Eric M Dube | Direktor | 6. Juni 2023 A | — | 0 | 0 | $0 |
| Stacey Denenberg Seltzer | Direktor | 6. Juni 2023 A | — | 0 | 0 | $0 |
| Paul W. Hoelscher | Direktor | 6. Juni 2023 A | — | 0 | 0 | $0 |
| Lon Cardon | Direktor | 8. April 2021 A | — | 0 | 0 | $0 |
| Kenneth Harrison Ph.D. | Direktor | 8. April 2021 A | — | 0 | 0 | $0 |
| Novo Holdings A/S | 10%-Eigentümer | 23. Juni 2023 S | 3.330.337 | 0 | 0 | $0 |
| Dylan Hartley | — | 7. August 2026 A | — | 0 | 0 | $0 |
| Andrew John Phillips | — | 7. August 2026 A | — | 0 | 0 | $0 |
| Valerie Malyvanh Jansen | — | 7. August 2026 A | — | 0 | 0 | $0 |
| Samuel Agresta | — | 7. August 2026 A | — | 0 | 0 | $0 |
| Jason A. Leverone | — | 7. August 2026 A | 18.802 | 0 | 1 | $-1.333 |
| Michael R Carruthers | — | 7. August 2026 A | — | 0 | 0 | $0 |
| Isaac Manke | — | 7. August 2026 A | 9.780 | 0 | 0 | $0 |
| Nicholas A Saccomano | — | 7. August 2026 A | 11.247 | 0 | 1 | $-378 |
| Liam Ratcliffe | — | 7. August 2026 A | — | 0 | 0 | $0 |
| Edward T. Mathers | — | 7. August 2026 A | 15.310 | 0 | 0 | $0 |
| Michael G Grey | — | 7. August 2026 A | 0 | 0 | 0 | $0 |
| Leonard Braden Michael | — | 7. Oktober 2024 J | 102.076 | 0 | 0 | $0 |
| Vineet R. Jindal | — | 10. Dezember 2021 A | 36.600 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 10 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| AI Biotechnology LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik | 7. April 2026 | 19,99% | Erste Einreichung | Passive Anlage | SEC |
| ACORN BIOVENTURES, L.P., ACORN CAPITAL ADVISORS GP, LLC, Anders Hove, ACORN BIOVENTURES 2, L.P., Acorn Capital Advisors GP 2, LLC ×2 Einreichungen | 30. Mai 2025 | 22,10% | Änderung | M&A / Verkauf | SEC |
| RiverVest Venture Fund III, L.P., RiverVest Venture Fund III (Ohio), L.P., RiverVest Venture Partners III (Ohio), LLC, RiverVest Venture Partners III, L.P., RiverVest Venture Partners III, LLC, RiverVest Venture Fund IV, L.P., RiverVest Venture Partners IV, L.P., RiverVest Venture Partners IV, LLC, John P. McKearn, Ph.D., Jay Schmelter, Thomas C. Melzer, Niall O'Donnell, Ph.D. | 21. Januar 2025 | 1,55% | Änderung | — | SEC |
| 8. Oktober 2024 | — | Erste Einreichung | — | SEC | |
| New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 Einreichungen | 8. Mai 2024 | — | Erste Einreichung | — | SEC |
| TANG CAPITAL PARTNERS, LP, TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, Concentra Biosciences, LLC | 26. Dezember 2023 | — | Erste Einreichung | Passive Anlage | SEC |
| Novo Holdings A/S ×5 Einreichungen | 15. Dezember 2023 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 30. Mai 2023 | — | Erste Einreichung | — | SEC |
| Abingworth LLP, Abingworth Bioventures 8, LP | 20. April 2021 | — | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 19. April 2021 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 5 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,02% | 88.693 SH | 21. August 2026 | Täglich |
| IWN · iShares Trust | 0,01% | 226.257 SH | 21. August 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 560.313 SH | 21. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 8.831 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 21.147 NS | 30. April 2026 | N-PORT |